Literature DB >> 2460011

Linked recognition of helper and cytotoxic antigenic determinants for the generation of cytotoxic T lymphocytes.

D Cassell1, J Forman.   

Abstract

These studies present a model for T-T collaboration for the generation of cytotoxic T lymphocytes. The in vitro CTL response against Qa-1 alloantigens in B6 Qa-1 congenic mice requires that animals are first primed in vivo with Qa-1 together with a second (helper) antigen. Both the antigen recognized by CTL (Qa-1) and Th (H-Y) must be presented on the same APC for successful priming. This findings is consistent with a linked recognition model whereby both molecules are presented on the same APC in order to accomplish close proximity between the two T cells. To further test this model, we demonstrated that in the absence of the helper antigen, H-Y, mice could be successfully primed against Qa-1 if coinoculated with a product of a Th, IL-2. We further showed that mice treated with anti-L3T4 antibodies could not be primed to Qa-1 even though the cells used for immunization expressed the H-Y helper antigen. Taken together, these results lend further support to a model of linked recognition between Th and CTL.P where close proximity allows for the lymphokine IL-2 to bind to its receptor on the CTL allowing for the successful induction of CTL.P.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460011     DOI: 10.1111/j.1749-6632.1988.tb36325.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

1.  In vivo induction of antigen-specific transplantation tolerance to Qa1a by exposure to alloantigen in the absence of T-cell help.

Authors:  M A Rees; A S Rosenberg; T I Munitz; A Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 2.  Biological Consequences of MHC-II Expression by Tumor Cells in Cancer.

Authors:  Margaret L Axelrod; Rebecca S Cook; Douglas B Johnson; Justin M Balko
Journal:  Clin Cancer Res       Date:  2018-11-21       Impact factor: 12.531

3.  Robust Anti-viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions.

Authors:  Sarah Eickhoff; Anna Brewitz; Michael Y Gerner; Frederick Klauschen; Karl Komander; Hiroaki Hemmi; Natalio Garbi; Tsuneyasu Kaisho; Ronald Nathan Germain; Wolfgang Kastenmüller
Journal:  Cell       Date:  2015-08-18       Impact factor: 41.582

4.  Functional cooperation between T helper cell determinants.

Authors:  M Gerloni; S Xiong; S Mukerjee; S P Schoenberger; M Croft; M Zanetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

5.  Attenuation of obliterative bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model.

Authors:  Jianguo Xu; Edilson Torres; Ana L Mora; Hyunsuk Shim; Allan Ramirez; David Neujahr; Kenneth L Brigham; Mauricio Rojas
Journal:  J Heart Lung Transplant       Date:  2008-12       Impact factor: 10.247

6.  Role of IL-2 secreted by PADRE-specific CD4+ T cells in enhancing E7-specific CD8+ T-cell immune responses.

Authors:  D Kim; A Monie; L He; Y-C Tsai; C-F Hung; T-C Wu
Journal:  Gene Ther       Date:  2008-02-14       Impact factor: 5.250

7.  A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cells.

Authors:  Xuelian Wang; Alessandro D Santin; Stefania Bellone; Sushil Gupta; Mayumi Nakagawa
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

Review 8.  Harnessing neoantigen specific CD4 T cells for cancer immunotherapy.

Authors:  Spencer E Brightman; Martin S Naradikian; Aaron M Miller; Stephen P Schoenberger
Journal:  J Leukoc Biol       Date:  2020-03-14       Impact factor: 4.962

9.  Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.

Authors:  A Vitiello; G Ishioka; H M Grey; R Rose; P Farness; R LaFond; L Yuan; F V Chisari; J Furze; R Bartholomeuz
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

10.  Evolutionary Pressure against MHC Class II Binding Cancer Mutations.

Authors:  Rachel Marty Pyke; Wesley Kurt Thompson; Rany M Salem; Joan Font-Burgada; Maurizio Zanetti; Hannah Carter
Journal:  Cell       Date:  2018-09-20       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.